Biomarkers, Bundled Payments, and Colorectal Cancer Care

William Ross, Patrick Lynch, Gottumukkala Raju, Alma Rodriguez, Thomas Burke, Lisa Hafemeister, Ernest Hawk, Xifeng Wu, Raymond N. DuBois, Lopa Mishra

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Changes in the management of cancers such as colorectal cancer (CRC) are urgently needed, as such cancers continue to be one of the most commonly diagnosed cancers; CRC accounts for 21% of all cancers and is responsible for mortalities second only to lung cancer in the United States. A comprehensive science-driven approach towards markedly improved early detection/screening to efficacious targeted therapeutics with clear diagnostic and prognostic markers is essential. In addition, further changes addressing rising costs, stemming from recent health care reform measures, will be brought about in part by changes in how care is reimbursed. For oncology, the advances in genomics and biomarkers have the potential to define subsets of patients who have a prognosis or response to a particular type of therapy that differs from the mean. Better definition of a cancer's behavior will facilitate developing care plans tailored to the patient. One method under study is episode-based payment or bundling, where one payment is made to a provider organization to cover all expenses associated with a discrete illness episode. Payments will be based on the average cost of care, with providers taking on a risk for overutilization and outliers. For providers to thrive in this environment, they will need to know what care a patient will require and the costs of that care. A science-driven "personalized approach" to cancer care has the potential to produce better outcomes with reductions in the use of ineffectual therapies and costs. This promising scenario is still in the future, but progress is being made, and the shape of things to come for cancer care in the age of genomics is becoming clearer.

Original languageEnglish (US)
Pages (from-to)16-22
Number of pages7
JournalGenes and Cancer
Volume3
Issue number1
DOIs
StatePublished - Jan 1 2012

Keywords

  • biomarkers
  • bundled payments
  • colorectal cancer
  • health care reform
  • health policy

ASJC Scopus subject areas

  • Genetics
  • Cancer Research

Fingerprint Dive into the research topics of 'Biomarkers, Bundled Payments, and Colorectal Cancer Care'. Together they form a unique fingerprint.

  • Cite this

    Ross, W., Lynch, P., Raju, G., Rodriguez, A., Burke, T., Hafemeister, L., Hawk, E., Wu, X., DuBois, R. N., & Mishra, L. (2012). Biomarkers, Bundled Payments, and Colorectal Cancer Care. Genes and Cancer, 3(1), 16-22. https://doi.org/10.1177/1947601912448958